Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patients' Preference for Participation in Medical Decision-Making: Secondary Analysis of the BEDSIDE-OUTSIDE Trial.
Becker C, Gross S, Gamp M, Beck K, Amacher SA, Mueller J, Bohren C, Blatter R, Schaefert R, Schuetz P, Leuppi J, Bassetti S, Hunziker S. Becker C, et al. Among authors: schuetz p. J Gen Intern Med. 2023 Apr;38(5):1180-1189. doi: 10.1007/s11606-022-07775-z. Epub 2022 Sep 9. J Gen Intern Med. 2023. PMID: 36085211 Free PMC article. Clinical Trial.
Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
Albrich WC, Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Bachli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Gaillat J, Schuetz P, Regez K, Bossart R, Schild U, Mueller B; ProREAL Study Team. Albrich WC, et al. Among authors: schuetz p. Arch Intern Med. 2012 May 14;172(9):715-22. doi: 10.1001/archinternmed.2012.770. Arch Intern Med. 2012. PMID: 22782201
Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance.
Dusemund F, Bucher B, Meyer S, Thomann R, Kühn F, Bassetti S, Sprenger M, Baechli E, Sigrist T, Schwietert M, Amin D, Hausfater P, Carre E, Schuetz P, Gaillat J, Regez K, Bossart R, Schild U, Müller B, Albrich WC; ProREAL Study Team. Dusemund F, et al. Among authors: schuetz p. Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):51-60. doi: 10.1007/s10096-012-1713-8. Epub 2012 Aug 12. Eur J Clin Microbiol Infect Dis. 2013. PMID: 22886090
Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.
Alan M, Grolimund E, Kutz A, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP study group. Alan M, et al. Among authors: schuetz p. J Intern Med. 2015 Aug;278(2):174-84. doi: 10.1111/joim.12341. Epub 2015 Jan 27. J Intern Med. 2015. PMID: 25529395 Free article. Clinical Trial.
Routine blood markers from different biological pathways improve early risk stratification in cardiac arrest patients: Results from the prospective, observational COMMUNICATE study.
Isenschmid C, Kalt J, Gamp M, Tondorf T, Becker C, Tisljar K, Locher S, Schuetz P, Marsch S, Hunziker S. Isenschmid C, et al. Among authors: schuetz p. Resuscitation. 2018 Sep;130:138-145. doi: 10.1016/j.resuscitation.2018.07.021. Epub 2018 Jul 20. Resuscitation. 2018. PMID: 30036589
Integrative hospital treatment in older patients to benchmark and improve outcome and length of stay - the In-HospiTOOL study.
Kutz A, Koch D, Conca A, Baechli C, Haubitz S, Regez K, Schild U, Caldara Z, Ebrahimi F, Bassetti S, Eckstein J, Beer J, Egloff M, Kaplan V, Ehmann T, Hoess C, Schaad H, Wagner U, de Geest S, Schuetz P, Mueller B. Kutz A, et al. Among authors: schuetz p. BMC Health Serv Res. 2019 Apr 23;19(1):237. doi: 10.1186/s12913-019-4045-x. BMC Health Serv Res. 2019. PMID: 31014343 Free PMC article.
501 results